Insider · CIK 0001616284

Saik Andrew

Reports to the SEC for 6 companies · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001616284

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	ARVNARVINAS, INC.S Sale	Chief Financial Officer	SSale	−5,696 sh	$8.16	−$46.5K	187,432
2026-06-10	MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+77K sh	—	—	77,000
2026-05-11	ARVNARVINAS, INC.S Sale	Chief Financial Officer	SSale	−11.1K sh	$9.94	−$111K	193,128
2026-02-26	ARVNARVINAS, INC.A Award	Chief Financial Officer	AAward	+45K sh	—	—	204,267
2026-02-26	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+67K sh	—	—	67,000
2026-02-13	ARVNARVINAS, INC.S Sale	Chief Financial Officer	SSale	−5,134 sh	$11.89	−$61K	159,267
2025-06-24	ARVNARVINAS, INC.S Sale	Chief Financial Officer	SSale	−5,700 sh	$7.61	−$43.4K	164,401
2025-06-10	MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2025-05-09	ARVNARVINAS, INC.A Award	Chief Financial Officer	AAward	+59.6K sh	—	—	170,101
2025-05-09	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+91K sh	—	—	91,000
2025-02-13	ARVNARVINAS, INC.A Award	Chief Financial Officer	AAward	+49.1K sh	—	—	110,501
2025-02-13	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+75K sh	—	—	74,960
2024-08-28	MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-07-15	MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	−80K sh	—	—	80,000
2024-06-24	ARVNARVINAS, INC.A Award	Chief Financial Officer	AAward	+61.4K sh	—	—	61,409
2024-06-24	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+94.4K sh	—	—	94,418
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.U Disposition from Tender	EVP & Chief Financial Officer	UDisposition from Tender	−23K sh	$19.00	−$437K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.D Disposition to Issuer	EVP & Chief Financial Officer	DDisposition to Issuer	−45.2K sh	$19.00	−$860K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	EVP & Chief Financial Officer	DDisposition to Issuer	−17.6K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	EVP & Chief Financial Officer	DDisposition to Issuer	−24K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	EVP & Chief Financial Officer	DDisposition to Issuer	−72.5K sh	—	—	0
2023-09-21	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Financial Officer	FTax Payment	−908 sh	$10.80	−$9,806.4	68,265
2023-06-21	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Financial Officer	FTax Payment	−908 sh	$11.74	−$10.7K	69,173
2023-03-21	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Financial Officer	FTax Payment	−909 sh	$14.19	−$12.9K	70,081
2023-01-27	INTERCEPT PHARMACEUTICALS, INC.A Award	EVP & Chief Financial Officer	AAward	+14.7K sh	—	—	70,990
2023-01-27	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	EVP & Chief Financial Officer	AAward	+24K sh	—	—	24,000
2022-12-31	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Financial Officer	FTax Payment	−718 sh	$12.37	−$8,881.66	56,290
2022-12-21	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Financial Officer	FTax Payment	−908 sh	$13.43	−$12.2K	57,008
2022-09-21	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Financial Officer	FTax Payment	−908 sh	$14.85	−$13.5K	57,916
2022-06-21	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Financial Officer	FTax Payment	−3,632 sh	$12.48	−$45.3K	58,824
2022-01-27	INTERCEPT PHARMACEUTICALS, INC.A Award	EVP & Chief Financial Officer	AAward	+10.3K sh	—	—	62,456
2022-01-27	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	EVP & Chief Financial Officer	AAward	+17.6K sh	—	—	17,600
2021-06-21	INTERCEPT PHARMACEUTICALS, INC.A Award	EVP & Chief Financial Officer	AAward	+52.2K sh	—	—	52,156
2021-06-21	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	EVP & Chief Financial Officer	AAward	+72.5K sh	—	—	72,540
2021-05-28	YARWYarrow Bioscience, Inc.A Award	Chief Financial Officer	AAward	+3,017 sh	$3.36	+$10.1K	116,468
2021-03-31	YARWYarrow Bioscience, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−762 sh	$6.84	−$5,212.08	113,451
2021-02-22	YARWYarrow Bioscience, Inc.A Award	Chief Financial Officer	AAward	+29.2K sh	—	—	114,213
2021-02-22	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+68.2K sh	—	—	68,162
2020-09-08	YARWYarrow Bioscience, Inc.P Purchase	Chief Financial Officer	PPurchase	+40K sh	$1.46	+$58.5K	340,000
2020-05-06	YARWYarrow Bioscience, Inc.A Award	Chief Financial Officer	AAward	+250K sh	—	—	300,000
2020-05-06	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+250K sh	—	—	250,000
2020-03-23	YARWYarrow Bioscience, Inc.A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2020-03-23	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2020-02-14	PDSBPDS Biotechnology CorpA Award	Director, Chief Financial Officer	AAward	+38.4K sh	$1.30	+$49.9K	42,549
2019-06-06	PDSBPDS Biotechnology Corp · Stock Option (Right To Purchase)A Award	Director, Chief Financial Officer	AAward	+62.7K sh	—	—	62,715
2019-03-15	PDSBPDS Biotechnology CorpM Exercise/Conversion	Director, Chief Financial Officer	MExercise/Conversion	+83K sh	—	—	82,999
2019-03-15	PDSBPDS Biotechnology Corp · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Financial Officer	MExercise/Conversion	−83K sh	—	—	0
2018-08-14	PDSBPDS Biotechnology Corp · Restricted Stock UnitsA Award	Director, Chief Financial Officer	AAward	+83K sh	—	—	82,999
2018-06-19	PDSBPDS Biotechnology Corp · Stock Option (Right To Purchase)A Award	Director, Chief Financial Officer	AAward	+166K sh	—	—	166,001
2018-03-01	PDSBPDS Biotechnology Corp · Stock Option (Right To Purchase)A Award	Director, Chief Financial Officer	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Jun 244
Saik Andrew0001628280-26-045286
SEC(opens sec.gov)
Jun 124
Saik Andrew0001616284-26-000002
SEC(opens sec.gov)
May 134
Saik Andrew0001628280-26-034615
SEC(opens sec.gov)
Mar 24
Saik Andrew0001628280-26-013531
SEC(opens sec.gov)
Feb 184
Saik Andrew0001628280-26-009306
SEC(opens sec.gov)
Jun 244
Saik Andrew0001655759-25-000109
SEC(opens sec.gov)
Jun 124
Saik Andrew0001415889-25-016933
SEC(opens sec.gov)
May 134
Saik Andrew0001655759-25-000091
SEC(opens sec.gov)
Feb 184
Saik Andrew0001655759-25-000027
SEC(opens sec.gov)
Aug 294
Saik Andrew0001415889-24-022537
SEC(opens sec.gov)
Jul 174
Saik Andrew0001415889-24-019668
SEC(opens sec.gov)
Jun 264
Saik Andrew0001655759-24-000105
SEC(opens sec.gov)
Nov 134
Saik Andrew0001104659-23-117093
SEC(opens sec.gov)

Companies

Address

C/O ARVINAS, INC. 5 SCIENCE PARK, 395 WINCHESTER AVE.

NEW HAVEN, CT, 06511